일시: 2024.10.25 (토)
장소: 계명대학교 동산병원 5층 세미나실(시온실)
진행 형태: 오프라인 및 온라인 하이브리드 심포지엄
* 해외 초청연자는 온라인 VOD 강의 및 실시간 토의로 진행됩니다.
| 09:25-09:30 | Opening Remark | 장병국 (대한간학회 지방간연구회 회장) |
| 09:30-09:35 | Welcoming Remark | 김윤준 (대한간학회 이사장) |
| Session 1. Basic and translational research in SLD |
좌장: 손주현 (을지의대) 황재석 (계명의대) |
|
| 09:35-09:55 | A novel genetic risk score predicting advanced fibrosis in MASLD | 양성욱 (연세대 생물학과) |
| 09:55-10:15 | Gut microbiomes and genetics as drivers of MASLD | 석기태 (한림의대) |
| 10:15-10:35 | A male mouse model for MASLD and hepatocellular carcinoma | 김하일 (KAIST) |
| 10:35-11:00 | MASLD as a risk factor for liver metastasis from non-hepatic cancers [VOD] | Ekihiro Seki (Cedars-Sinai Medical Center, USA) |
| 11:00-11:15 | Coffee Break | |
| Session 2. Definition and clinical implications of SLD |
좌장: 박상훈 (한림의대) 김윤준 (서울의대) |
|
| 11:15-11:35 | Diagnostic criteria for SLD: updates, pitfalls, and practical insights | 조영윤 (중앙의대) |
| 11:35-11:55 | Risk of cardiovascular disease in MASLD: impact of steatosis vs. fibrosis | 김정희 (한림의대) |
| 11:55-12:15 | Cut-off levels in noninvasive tests for MASLD, MetALD, and ALD: same or different? | 유정주 (순천향의대) |
| 12:15-12:30 | Panel discussion | 정승원 (순천향의대), 박수영 (경북의대), 김문영 (연세원주의대) |
| 12:30-13:30 | Lunch | |
| Session 3. Recent advances in SLD research |
좌장: 장병국 (계명의대) 김승업 (연세의대) |
|
| 13:30-13:55 | Global landscape of clinical trials in MASLD: current status and future perspectives [VOD] | Vincent Wong (The Chinese Univ. of Hong Kong, China) |
| 13:55-14:15 | Recent research in noninvasive biomarkers for the clinical management of MASLD | 이혜원 (연세의대) |
| 14:15-14:40 | Genetic Landscape of MASLD in East Asia [VOD] | Yuya Seko (Kyoto Prefectural University of Medicine, Japan) |
| 14:40-15:00 | Recent trends and future directions of SLD research in Asia | 김원 (CMH Editor-in-Chief) |
| 15:00-15:15 | Coffee Break | |
| Session 4. Clinical issues in MASLD management |
좌장: 정숙향 (서울의대) 이진우 (인하의대) |
|
| 15:15-15:35 | Management of obesity in MASLD: anti-obesity drugs vs. bariatric surgery | 김미경 (계명의대 내분비내과) |
| 15:35-15:55 | Clinical impact and management of non-obese patients with MASLD | 신현재 (서울의대) |
| 15:55-16:15 | Chemoprevention of MASLD-related hepatocellular carcinoma | 송정은 (대구가톨릭의대) |
| 16:15-16:30 | Panel discussion | 김상균 (순천향의대), 전대원 (한양의대), 정영걸 (고려의대) |
| 16:30-16:40 | Closing Remark | 정숙향 (대한간학회 회장) |